nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—ABCB1—colon cancer	0.282	1	CbGaD
Clopidogrel—CES1—Capecitabine—colon cancer	0.243	0.41	CbGbCtD
Clopidogrel—CES1—Irinotecan—colon cancer	0.15	0.253	CbGbCtD
Clopidogrel—CYP2B6—Irinotecan—colon cancer	0.0288	0.0486	CbGbCtD
Clopidogrel—CYP2C9—Capecitabine—colon cancer	0.0246	0.0416	CbGbCtD
Clopidogrel—CYP3A5—Irinotecan—colon cancer	0.0227	0.0383	CbGbCtD
Clopidogrel—CYP2C8—Fluorouracil—colon cancer	0.0209	0.0353	CbGbCtD
Clopidogrel—CYP3A5—Vincristine—colon cancer	0.0198	0.0335	CbGbCtD
Clopidogrel—CYP1A2—Fluorouracil—colon cancer	0.0162	0.0273	CbGbCtD
Clopidogrel—ABCB1—Irinotecan—colon cancer	0.0148	0.0249	CbGbCtD
Clopidogrel—CYP2C9—Fluorouracil—colon cancer	0.0146	0.0246	CbGbCtD
Clopidogrel—ABCB1—Vincristine—colon cancer	0.0129	0.0218	CbGbCtD
Clopidogrel—CYP3A4—Irinotecan—colon cancer	0.00884	0.0149	CbGbCtD
Clopidogrel—ABCB1—Methotrexate—colon cancer	0.00781	0.0132	CbGbCtD
Clopidogrel—CYP3A4—Vincristine—colon cancer	0.00773	0.013	CbGbCtD
Clopidogrel—CES1—gall bladder—colon cancer	0.00115	0.121	CbGeAlD
Clopidogrel—P2RY12—epithelium—colon cancer	0.00114	0.119	CbGeAlD
Clopidogrel—CES1—lymphoid tissue—colon cancer	0.00046	0.0483	CbGeAlD
Clopidogrel—CES1—digestive system—colon cancer	0.000454	0.0477	CbGeAlD
Clopidogrel—CES1—liver—colon cancer	0.000338	0.0356	CbGeAlD
Clopidogrel—ABCB1—blood vessel—colon cancer	0.000287	0.0302	CbGeAlD
Clopidogrel—CYP2C8—renal system—colon cancer	0.000271	0.0284	CbGeAlD
Clopidogrel—CES1—lymph node—colon cancer	0.000259	0.0273	CbGeAlD
Clopidogrel—CYP2C19—digestive system—colon cancer	0.000254	0.0267	CbGeAlD
Clopidogrel—CYP1A2—renal system—colon cancer	0.000253	0.0266	CbGeAlD
Clopidogrel—CYP3A5—renal system—colon cancer	0.000244	0.0257	CbGeAlD
Clopidogrel—Muscle spasms—Irinotecan—colon cancer	0.000244	0.0021	CcSEcCtD
Clopidogrel—Asthma—Capecitabine—colon cancer	0.000243	0.0021	CcSEcCtD
Clopidogrel—CYP2B6—renal system—colon cancer	0.000243	0.0255	CbGeAlD
Clopidogrel—Anaemia—Vincristine—colon cancer	0.00024	0.00208	CcSEcCtD
Clopidogrel—Bronchospasm—Capecitabine—colon cancer	0.000239	0.00207	CcSEcCtD
Clopidogrel—Angina pectoris—Capecitabine—colon cancer	0.000237	0.00205	CcSEcCtD
Clopidogrel—Anaemia—Irinotecan—colon cancer	0.000234	0.00202	CcSEcCtD
Clopidogrel—Bronchitis—Capecitabine—colon cancer	0.000234	0.00202	CcSEcCtD
Clopidogrel—Vertigo—Vincristine—colon cancer	0.000234	0.00202	CcSEcCtD
Clopidogrel—Leukopenia—Vincristine—colon cancer	0.000233	0.00201	CcSEcCtD
Clopidogrel—Pancytopenia—Capecitabine—colon cancer	0.000231	0.002	CcSEcCtD
Clopidogrel—Vertigo—Irinotecan—colon cancer	0.000228	0.00197	CcSEcCtD
Clopidogrel—Neutropenia—Capecitabine—colon cancer	0.000228	0.00197	CcSEcCtD
Clopidogrel—Syncope—Irinotecan—colon cancer	0.000227	0.00196	CcSEcCtD
Clopidogrel—Renal failure acute—Methotrexate—colon cancer	0.000227	0.00196	CcSEcCtD
Clopidogrel—Leukopenia—Irinotecan—colon cancer	0.000227	0.00196	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Capecitabine—colon cancer	0.000226	0.00195	CcSEcCtD
Clopidogrel—Hypertension—Vincristine—colon cancer	0.000225	0.00194	CcSEcCtD
Clopidogrel—CYP2C19—vagina—colon cancer	0.000225	0.0236	CbGeAlD
Clopidogrel—Anaemia—Fluorouracil—colon cancer	0.000224	0.00194	CcSEcCtD
Clopidogrel—Loss of consciousness—Irinotecan—colon cancer	0.000223	0.00192	CcSEcCtD
Clopidogrel—Myalgia—Vincristine—colon cancer	0.000221	0.00191	CcSEcCtD
Clopidogrel—Cough—Irinotecan—colon cancer	0.000221	0.00191	CcSEcCtD
Clopidogrel—Hypertension—Irinotecan—colon cancer	0.000219	0.00189	CcSEcCtD
Clopidogrel—Pneumonia—Capecitabine—colon cancer	0.000218	0.00189	CcSEcCtD
Clopidogrel—Leukopenia—Fluorouracil—colon cancer	0.000217	0.00188	CcSEcCtD
Clopidogrel—Anaphylactoid reaction—Methotrexate—colon cancer	0.000217	0.00187	CcSEcCtD
Clopidogrel—Depression—Capecitabine—colon cancer	0.000216	0.00187	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000215	0.00186	CcSEcCtD
Clopidogrel—Renal failure—Capecitabine—colon cancer	0.000213	0.00184	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Capecitabine—colon cancer	0.000213	0.00184	CcSEcCtD
Clopidogrel—Oedema—Vincristine—colon cancer	0.000212	0.00183	CcSEcCtD
Clopidogrel—Anaphylactic shock—Vincristine—colon cancer	0.000212	0.00183	CcSEcCtD
Clopidogrel—Stomatitis—Capecitabine—colon cancer	0.000212	0.00183	CcSEcCtD
Clopidogrel—Infection—Vincristine—colon cancer	0.000211	0.00182	CcSEcCtD
Clopidogrel—Urinary tract infection—Capecitabine—colon cancer	0.000211	0.00182	CcSEcCtD
Clopidogrel—Conjunctivitis—Capecitabine—colon cancer	0.000211	0.00182	CcSEcCtD
Clopidogrel—Osteoarthritis—Methotrexate—colon cancer	0.00021	0.00181	CcSEcCtD
Clopidogrel—Confusional state—Irinotecan—colon cancer	0.000208	0.0018	CcSEcCtD
Clopidogrel—Nervous system disorder—Vincristine—colon cancer	0.000208	0.0018	CcSEcCtD
Clopidogrel—CYP1A2—digestive system—colon cancer	0.000208	0.0218	CbGeAlD
Clopidogrel—Haematuria—Capecitabine—colon cancer	0.000207	0.00179	CcSEcCtD
Clopidogrel—Anaphylactic shock—Irinotecan—colon cancer	0.000207	0.00179	CcSEcCtD
Clopidogrel—Oedema—Irinotecan—colon cancer	0.000207	0.00179	CcSEcCtD
Clopidogrel—Myalgia—Fluorouracil—colon cancer	0.000207	0.00178	CcSEcCtD
Clopidogrel—Chest pain—Fluorouracil—colon cancer	0.000207	0.00178	CcSEcCtD
Clopidogrel—Infection—Irinotecan—colon cancer	0.000205	0.00177	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Capecitabine—colon cancer	0.000205	0.00177	CcSEcCtD
Clopidogrel—Epistaxis—Capecitabine—colon cancer	0.000205	0.00177	CcSEcCtD
Clopidogrel—Shock—Irinotecan—colon cancer	0.000203	0.00176	CcSEcCtD
Clopidogrel—Nervous system disorder—Irinotecan—colon cancer	0.000203	0.00175	CcSEcCtD
Clopidogrel—Agranulocytosis—Capecitabine—colon cancer	0.000202	0.00175	CcSEcCtD
Clopidogrel—CYP2B6—lymphoid tissue—colon cancer	0.000202	0.0212	CbGeAlD
Clopidogrel—CYP3A5—digestive system—colon cancer	0.0002	0.021	CbGeAlD
Clopidogrel—Confusional state—Fluorouracil—colon cancer	0.0002	0.00173	CcSEcCtD
Clopidogrel—CYP2B6—digestive system—colon cancer	0.000199	0.0209	CbGeAlD
Clopidogrel—Hypotension—Vincristine—colon cancer	0.000198	0.00171	CcSEcCtD
Clopidogrel—Oedema—Fluorouracil—colon cancer	0.000198	0.00171	CcSEcCtD
Clopidogrel—Anaphylactic shock—Fluorouracil—colon cancer	0.000198	0.00171	CcSEcCtD
Clopidogrel—CYP2C9—digestive system—colon cancer	0.000197	0.0207	CbGeAlD
Clopidogrel—Infection—Fluorouracil—colon cancer	0.000197	0.0017	CcSEcCtD
Clopidogrel—CYP2C8—vagina—colon cancer	0.000196	0.0206	CbGeAlD
Clopidogrel—Haemoglobin—Capecitabine—colon cancer	0.000196	0.00169	CcSEcCtD
Clopidogrel—Rhinitis—Capecitabine—colon cancer	0.000195	0.00169	CcSEcCtD
Clopidogrel—Hepatitis—Capecitabine—colon cancer	0.000195	0.00168	CcSEcCtD
Clopidogrel—Haemorrhage—Capecitabine—colon cancer	0.000195	0.00168	CcSEcCtD
Clopidogrel—Nervous system disorder—Fluorouracil—colon cancer	0.000194	0.00168	CcSEcCtD
Clopidogrel—Hypoaesthesia—Capecitabine—colon cancer	0.000194	0.00167	CcSEcCtD
Clopidogrel—Liver function test abnormal—Methotrexate—colon cancer	0.000194	0.00167	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Vincristine—colon cancer	0.000193	0.00167	CcSEcCtD
Clopidogrel—Hypotension—Irinotecan—colon cancer	0.000193	0.00167	CcSEcCtD
Clopidogrel—Urinary tract disorder—Capecitabine—colon cancer	0.000192	0.00166	CcSEcCtD
Clopidogrel—Insomnia—Vincristine—colon cancer	0.000192	0.00166	CcSEcCtD
Clopidogrel—Oedema peripheral—Capecitabine—colon cancer	0.000192	0.00166	CcSEcCtD
Clopidogrel—Urethral disorder—Capecitabine—colon cancer	0.000191	0.00165	CcSEcCtD
Clopidogrel—Paraesthesia—Vincristine—colon cancer	0.000191	0.00165	CcSEcCtD
Clopidogrel—CYP2C19—liver—colon cancer	0.000189	0.0199	CbGeAlD
Clopidogrel—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000189	0.00163	CcSEcCtD
Clopidogrel—Visual impairment—Capecitabine—colon cancer	0.000188	0.00162	CcSEcCtD
Clopidogrel—Insomnia—Irinotecan—colon cancer	0.000187	0.00162	CcSEcCtD
Clopidogrel—Paraesthesia—Irinotecan—colon cancer	0.000186	0.0016	CcSEcCtD
Clopidogrel—Hypotension—Fluorouracil—colon cancer	0.000185	0.0016	CcSEcCtD
Clopidogrel—Dyspnoea—Irinotecan—colon cancer	0.000184	0.00159	CcSEcCtD
Clopidogrel—Erythema multiforme—Capecitabine—colon cancer	0.000184	0.00159	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Vincristine—colon cancer	0.000183	0.00158	CcSEcCtD
Clopidogrel—CYP3A4—renal system—colon cancer	0.000183	0.0193	CbGeAlD
Clopidogrel—Fatigue—Vincristine—colon cancer	0.000183	0.00158	CcSEcCtD
Clopidogrel—Eye disorder—Capecitabine—colon cancer	0.000182	0.00157	CcSEcCtD
Clopidogrel—Dyspepsia—Irinotecan—colon cancer	0.000182	0.00157	CcSEcCtD
Clopidogrel—Tinnitus—Capecitabine—colon cancer	0.000182	0.00157	CcSEcCtD
Clopidogrel—Pain—Vincristine—colon cancer	0.000182	0.00157	CcSEcCtD
Clopidogrel—Constipation—Vincristine—colon cancer	0.000182	0.00157	CcSEcCtD
Clopidogrel—Asthma—Methotrexate—colon cancer	0.000181	0.00157	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00018	0.00156	CcSEcCtD
Clopidogrel—Eosinophilia—Methotrexate—colon cancer	0.000179	0.00155	CcSEcCtD
Clopidogrel—Insomnia—Fluorouracil—colon cancer	0.000179	0.00155	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Irinotecan—colon cancer	0.000179	0.00154	CcSEcCtD
Clopidogrel—Fatigue—Irinotecan—colon cancer	0.000178	0.00154	CcSEcCtD
Clopidogrel—Paraesthesia—Fluorouracil—colon cancer	0.000178	0.00154	CcSEcCtD
Clopidogrel—Pancreatitis—Methotrexate—colon cancer	0.000178	0.00153	CcSEcCtD
Clopidogrel—CYP3A5—vagina—colon cancer	0.000177	0.0186	CbGeAlD
Clopidogrel—Constipation—Irinotecan—colon cancer	0.000177	0.00153	CcSEcCtD
Clopidogrel—Pain—Irinotecan—colon cancer	0.000177	0.00153	CcSEcCtD
Clopidogrel—Angiopathy—Capecitabine—colon cancer	0.000177	0.00153	CcSEcCtD
Clopidogrel—Dyspnoea—Fluorouracil—colon cancer	0.000177	0.00153	CcSEcCtD
Clopidogrel—Immune system disorder—Capecitabine—colon cancer	0.000176	0.00152	CcSEcCtD
Clopidogrel—CYP2B6—vagina—colon cancer	0.000176	0.0185	CbGeAlD
Clopidogrel—Mediastinal disorder—Capecitabine—colon cancer	0.000176	0.00152	CcSEcCtD
Clopidogrel—Dyspepsia—Fluorouracil—colon cancer	0.000174	0.00151	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Vincristine—colon cancer	0.000174	0.0015	CcSEcCtD
Clopidogrel—Pancytopenia—Methotrexate—colon cancer	0.000172	0.00149	CcSEcCtD
Clopidogrel—ABCB1—embryo—colon cancer	0.000171	0.018	CbGeAlD
Clopidogrel—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000171	0.00148	CcSEcCtD
Clopidogrel—Mental disorder—Capecitabine—colon cancer	0.000171	0.00147	CcSEcCtD
Clopidogrel—Feeling abnormal—Irinotecan—colon cancer	0.00017	0.00147	CcSEcCtD
Clopidogrel—Malnutrition—Capecitabine—colon cancer	0.00017	0.00146	CcSEcCtD
Clopidogrel—Neutropenia—Methotrexate—colon cancer	0.000169	0.00146	CcSEcCtD
Clopidogrel—Pain—Fluorouracil—colon cancer	0.000169	0.00146	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Irinotecan—colon cancer	0.000169	0.00146	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Methotrexate—colon cancer	0.000168	0.00145	CcSEcCtD
Clopidogrel—Abdominal pain—Vincristine—colon cancer	0.000168	0.00145	CcSEcCtD
Clopidogrel—Body temperature increased—Vincristine—colon cancer	0.000168	0.00145	CcSEcCtD
Clopidogrel—Flatulence—Capecitabine—colon cancer	0.000167	0.00144	CcSEcCtD
Clopidogrel—CYP2C8—liver—colon cancer	0.000165	0.0174	CbGeAlD
Clopidogrel—Back pain—Capecitabine—colon cancer	0.000164	0.00142	CcSEcCtD
Clopidogrel—Abdominal pain—Irinotecan—colon cancer	0.000163	0.00141	CcSEcCtD
Clopidogrel—Body temperature increased—Irinotecan—colon cancer	0.000163	0.00141	CcSEcCtD
Clopidogrel—Feeling abnormal—Fluorouracil—colon cancer	0.000163	0.00141	CcSEcCtD
Clopidogrel—Muscle spasms—Capecitabine—colon cancer	0.000163	0.00141	CcSEcCtD
Clopidogrel—Pneumonia—Methotrexate—colon cancer	0.000162	0.0014	CcSEcCtD
Clopidogrel—Depression—Methotrexate—colon cancer	0.000161	0.00139	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00016	0.00138	CcSEcCtD
Clopidogrel—Renal failure—Methotrexate—colon cancer	0.000159	0.00137	CcSEcCtD
Clopidogrel—Stomatitis—Methotrexate—colon cancer	0.000157	0.00136	CcSEcCtD
Clopidogrel—Urticaria—Fluorouracil—colon cancer	0.000157	0.00136	CcSEcCtD
Clopidogrel—Conjunctivitis—Methotrexate—colon cancer	0.000157	0.00136	CcSEcCtD
Clopidogrel—Anaemia—Capecitabine—colon cancer	0.000157	0.00135	CcSEcCtD
Clopidogrel—Body temperature increased—Fluorouracil—colon cancer	0.000157	0.00135	CcSEcCtD
Clopidogrel—Hypersensitivity—Vincristine—colon cancer	0.000156	0.00135	CcSEcCtD
Clopidogrel—CYP1A2—liver—colon cancer	0.000155	0.0163	CbGeAlD
Clopidogrel—Haematuria—Methotrexate—colon cancer	0.000154	0.00133	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Methotrexate—colon cancer	0.000153	0.00132	CcSEcCtD
Clopidogrel—Epistaxis—Methotrexate—colon cancer	0.000152	0.00132	CcSEcCtD
Clopidogrel—Vertigo—Capecitabine—colon cancer	0.000152	0.00132	CcSEcCtD
Clopidogrel—Hypersensitivity—Irinotecan—colon cancer	0.000152	0.00132	CcSEcCtD
Clopidogrel—Asthenia—Vincristine—colon cancer	0.000152	0.00132	CcSEcCtD
Clopidogrel—Syncope—Capecitabine—colon cancer	0.000152	0.00131	CcSEcCtD
Clopidogrel—Leukopenia—Capecitabine—colon cancer	0.000152	0.00131	CcSEcCtD
Clopidogrel—Agranulocytosis—Methotrexate—colon cancer	0.000151	0.0013	CcSEcCtD
Clopidogrel—CYP3A4—digestive system—colon cancer	0.00015	0.0158	CbGeAlD
Clopidogrel—Palpitations—Capecitabine—colon cancer	0.00015	0.00129	CcSEcCtD
Clopidogrel—CYP3A5—liver—colon cancer	0.000149	0.0157	CbGeAlD
Clopidogrel—Loss of consciousness—Capecitabine—colon cancer	0.000149	0.00129	CcSEcCtD
Clopidogrel—Asthenia—Irinotecan—colon cancer	0.000148	0.00128	CcSEcCtD
Clopidogrel—CYP2B6—liver—colon cancer	0.000148	0.0156	CbGeAlD
Clopidogrel—Cough—Capecitabine—colon cancer	0.000148	0.00128	CcSEcCtD
Clopidogrel—CYP2C9—liver—colon cancer	0.000147	0.0154	CbGeAlD
Clopidogrel—Hypertension—Capecitabine—colon cancer	0.000146	0.00126	CcSEcCtD
Clopidogrel—Hypersensitivity—Fluorouracil—colon cancer	0.000146	0.00126	CcSEcCtD
Clopidogrel—Haemoglobin—Methotrexate—colon cancer	0.000146	0.00126	CcSEcCtD
Clopidogrel—Diarrhoea—Vincristine—colon cancer	0.000145	0.00126	CcSEcCtD
Clopidogrel—Haemorrhage—Methotrexate—colon cancer	0.000145	0.00125	CcSEcCtD
Clopidogrel—Hepatitis—Methotrexate—colon cancer	0.000145	0.00125	CcSEcCtD
Clopidogrel—Arthralgia—Capecitabine—colon cancer	0.000144	0.00125	CcSEcCtD
Clopidogrel—Chest pain—Capecitabine—colon cancer	0.000144	0.00125	CcSEcCtD
Clopidogrel—Myalgia—Capecitabine—colon cancer	0.000144	0.00125	CcSEcCtD
Clopidogrel—Anxiety—Capecitabine—colon cancer	0.000144	0.00124	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000143	0.00124	CcSEcCtD
Clopidogrel—Urinary tract disorder—Methotrexate—colon cancer	0.000143	0.00124	CcSEcCtD
Clopidogrel—Urethral disorder—Methotrexate—colon cancer	0.000142	0.00123	CcSEcCtD
Clopidogrel—Diarrhoea—Irinotecan—colon cancer	0.000141	0.00122	CcSEcCtD
Clopidogrel—Dizziness—Vincristine—colon cancer	0.00014	0.00121	CcSEcCtD
Clopidogrel—Pruritus—Fluorouracil—colon cancer	0.00014	0.00121	CcSEcCtD
Clopidogrel—ABCB1—epithelium—colon cancer	0.00014	0.0147	CbGeAlD
Clopidogrel—Visual impairment—Methotrexate—colon cancer	0.00014	0.00121	CcSEcCtD
Clopidogrel—Confusional state—Capecitabine—colon cancer	0.00014	0.00121	CcSEcCtD
Clopidogrel—Oedema—Capecitabine—colon cancer	0.000138	0.0012	CcSEcCtD
Clopidogrel—Infection—Capecitabine—colon cancer	0.000137	0.00119	CcSEcCtD
Clopidogrel—Erythema multiforme—Methotrexate—colon cancer	0.000137	0.00118	CcSEcCtD
Clopidogrel—Dizziness—Irinotecan—colon cancer	0.000137	0.00118	CcSEcCtD
Clopidogrel—Shock—Capecitabine—colon cancer	0.000136	0.00118	CcSEcCtD
Clopidogrel—Nervous system disorder—Capecitabine—colon cancer	0.000136	0.00117	CcSEcCtD
Clopidogrel—Eye disorder—Methotrexate—colon cancer	0.000136	0.00117	CcSEcCtD
Clopidogrel—Diarrhoea—Fluorouracil—colon cancer	0.000135	0.00117	CcSEcCtD
Clopidogrel—Tinnitus—Methotrexate—colon cancer	0.000135	0.00117	CcSEcCtD
Clopidogrel—Vomiting—Vincristine—colon cancer	0.000135	0.00117	CcSEcCtD
Clopidogrel—Skin disorder—Capecitabine—colon cancer	0.000134	0.00116	CcSEcCtD
Clopidogrel—Rash—Vincristine—colon cancer	0.000134	0.00116	CcSEcCtD
Clopidogrel—Dermatitis—Vincristine—colon cancer	0.000134	0.00116	CcSEcCtD
Clopidogrel—Headache—Vincristine—colon cancer	0.000133	0.00115	CcSEcCtD
Clopidogrel—Angiopathy—Methotrexate—colon cancer	0.000132	0.00114	CcSEcCtD
Clopidogrel—Vomiting—Irinotecan—colon cancer	0.000131	0.00114	CcSEcCtD
Clopidogrel—Immune system disorder—Methotrexate—colon cancer	0.000131	0.00113	CcSEcCtD
Clopidogrel—Dizziness—Fluorouracil—colon cancer	0.000131	0.00113	CcSEcCtD
Clopidogrel—Mediastinal disorder—Methotrexate—colon cancer	0.000131	0.00113	CcSEcCtD
Clopidogrel—Rash—Irinotecan—colon cancer	0.00013	0.00113	CcSEcCtD
Clopidogrel—Dermatitis—Irinotecan—colon cancer	0.00013	0.00113	CcSEcCtD
Clopidogrel—ABCB1—renal system—colon cancer	0.00013	0.0136	CbGeAlD
Clopidogrel—Headache—Irinotecan—colon cancer	0.00013	0.00112	CcSEcCtD
Clopidogrel—Hypotension—Capecitabine—colon cancer	0.000129	0.00112	CcSEcCtD
Clopidogrel—Mental disorder—Methotrexate—colon cancer	0.000127	0.0011	CcSEcCtD
Clopidogrel—Malnutrition—Methotrexate—colon cancer	0.000126	0.00109	CcSEcCtD
Clopidogrel—Nausea—Vincristine—colon cancer	0.000126	0.00109	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000126	0.00109	CcSEcCtD
Clopidogrel—Vomiting—Fluorouracil—colon cancer	0.000126	0.00109	CcSEcCtD
Clopidogrel—Insomnia—Capecitabine—colon cancer	0.000125	0.00108	CcSEcCtD
Clopidogrel—Rash—Fluorouracil—colon cancer	0.000125	0.00108	CcSEcCtD
Clopidogrel—Dermatitis—Fluorouracil—colon cancer	0.000125	0.00108	CcSEcCtD
Clopidogrel—Paraesthesia—Capecitabine—colon cancer	0.000124	0.00107	CcSEcCtD
Clopidogrel—Headache—Fluorouracil—colon cancer	0.000124	0.00107	CcSEcCtD
Clopidogrel—Dyspnoea—Capecitabine—colon cancer	0.000123	0.00107	CcSEcCtD
Clopidogrel—Nausea—Irinotecan—colon cancer	0.000123	0.00106	CcSEcCtD
Clopidogrel—Back pain—Methotrexate—colon cancer	0.000122	0.00105	CcSEcCtD
Clopidogrel—Dyspepsia—Capecitabine—colon cancer	0.000122	0.00105	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Capecitabine—colon cancer	0.000119	0.00103	CcSEcCtD
Clopidogrel—Fatigue—Capecitabine—colon cancer	0.000119	0.00103	CcSEcCtD
Clopidogrel—Constipation—Capecitabine—colon cancer	0.000118	0.00102	CcSEcCtD
Clopidogrel—Pain—Capecitabine—colon cancer	0.000118	0.00102	CcSEcCtD
Clopidogrel—Nausea—Fluorouracil—colon cancer	0.000118	0.00102	CcSEcCtD
Clopidogrel—Anaemia—Methotrexate—colon cancer	0.000117	0.00101	CcSEcCtD
Clopidogrel—Feeling abnormal—Capecitabine—colon cancer	0.000114	0.000985	CcSEcCtD
Clopidogrel—Vertigo—Methotrexate—colon cancer	0.000113	0.00098	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Capecitabine—colon cancer	0.000113	0.000978	CcSEcCtD
Clopidogrel—Leukopenia—Methotrexate—colon cancer	0.000113	0.000976	CcSEcCtD
Clopidogrel—CYP3A4—liver—colon cancer	0.000112	0.0118	CbGeAlD
Clopidogrel—Cough—Methotrexate—colon cancer	0.00011	0.000952	CcSEcCtD
Clopidogrel—Urticaria—Capecitabine—colon cancer	0.00011	0.00095	CcSEcCtD
Clopidogrel—Abdominal pain—Capecitabine—colon cancer	0.000109	0.000945	CcSEcCtD
Clopidogrel—Body temperature increased—Capecitabine—colon cancer	0.000109	0.000945	CcSEcCtD
Clopidogrel—ABCB1—lymphoid tissue—colon cancer	0.000108	0.0113	CbGeAlD
Clopidogrel—Arthralgia—Methotrexate—colon cancer	0.000107	0.000928	CcSEcCtD
Clopidogrel—Chest pain—Methotrexate—colon cancer	0.000107	0.000928	CcSEcCtD
Clopidogrel—Myalgia—Methotrexate—colon cancer	0.000107	0.000928	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000107	0.000922	CcSEcCtD
Clopidogrel—ABCB1—digestive system—colon cancer	0.000106	0.0112	CbGeAlD
Clopidogrel—Confusional state—Methotrexate—colon cancer	0.000104	0.000897	CcSEcCtD
Clopidogrel—Anaphylactic shock—Methotrexate—colon cancer	0.000103	0.00089	CcSEcCtD
Clopidogrel—Infection—Methotrexate—colon cancer	0.000102	0.000884	CcSEcCtD
Clopidogrel—Hypersensitivity—Capecitabine—colon cancer	0.000102	0.000881	CcSEcCtD
Clopidogrel—Nervous system disorder—Methotrexate—colon cancer	0.000101	0.000873	CcSEcCtD
Clopidogrel—Skin disorder—Methotrexate—colon cancer	0.0001	0.000864	CcSEcCtD
Clopidogrel—Asthenia—Capecitabine—colon cancer	9.93e-05	0.000858	CcSEcCtD
Clopidogrel—ABCB1—bone marrow—colon cancer	9.81e-05	0.0103	CbGeAlD
Clopidogrel—Pruritus—Capecitabine—colon cancer	9.79e-05	0.000846	CcSEcCtD
Clopidogrel—Hypotension—Methotrexate—colon cancer	9.63e-05	0.000832	CcSEcCtD
Clopidogrel—Diarrhoea—Capecitabine—colon cancer	9.47e-05	0.000818	CcSEcCtD
Clopidogrel—ABCB1—vagina—colon cancer	9.4e-05	0.00987	CbGeAlD
Clopidogrel—Musculoskeletal discomfort—Methotrexate—colon cancer	9.39e-05	0.000811	CcSEcCtD
Clopidogrel—Insomnia—Methotrexate—colon cancer	9.32e-05	0.000805	CcSEcCtD
Clopidogrel—Paraesthesia—Methotrexate—colon cancer	9.25e-05	0.000799	CcSEcCtD
Clopidogrel—Dyspnoea—Methotrexate—colon cancer	9.18e-05	0.000793	CcSEcCtD
Clopidogrel—Dizziness—Capecitabine—colon cancer	9.15e-05	0.000791	CcSEcCtD
Clopidogrel—Dyspepsia—Methotrexate—colon cancer	9.07e-05	0.000783	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Methotrexate—colon cancer	8.89e-05	0.000768	CcSEcCtD
Clopidogrel—Fatigue—Methotrexate—colon cancer	8.88e-05	0.000767	CcSEcCtD
Clopidogrel—Pain—Methotrexate—colon cancer	8.81e-05	0.000761	CcSEcCtD
Clopidogrel—Vomiting—Capecitabine—colon cancer	8.8e-05	0.00076	CcSEcCtD
Clopidogrel—Rash—Capecitabine—colon cancer	8.73e-05	0.000754	CcSEcCtD
Clopidogrel—Dermatitis—Capecitabine—colon cancer	8.72e-05	0.000753	CcSEcCtD
Clopidogrel—Headache—Capecitabine—colon cancer	8.67e-05	0.000749	CcSEcCtD
Clopidogrel—Feeling abnormal—Methotrexate—colon cancer	8.49e-05	0.000733	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Methotrexate—colon cancer	8.42e-05	0.000728	CcSEcCtD
Clopidogrel—Nausea—Capecitabine—colon cancer	8.22e-05	0.00071	CcSEcCtD
Clopidogrel—Urticaria—Methotrexate—colon cancer	8.18e-05	0.000707	CcSEcCtD
Clopidogrel—Abdominal pain—Methotrexate—colon cancer	8.14e-05	0.000704	CcSEcCtD
Clopidogrel—Body temperature increased—Methotrexate—colon cancer	8.14e-05	0.000704	CcSEcCtD
Clopidogrel—ABCB1—liver—colon cancer	7.93e-05	0.00833	CbGeAlD
Clopidogrel—Hypersensitivity—Methotrexate—colon cancer	7.59e-05	0.000656	CcSEcCtD
Clopidogrel—Asthenia—Methotrexate—colon cancer	7.39e-05	0.000639	CcSEcCtD
Clopidogrel—Pruritus—Methotrexate—colon cancer	7.29e-05	0.00063	CcSEcCtD
Clopidogrel—Diarrhoea—Methotrexate—colon cancer	7.05e-05	0.000609	CcSEcCtD
Clopidogrel—Dizziness—Methotrexate—colon cancer	6.81e-05	0.000589	CcSEcCtD
Clopidogrel—Vomiting—Methotrexate—colon cancer	6.55e-05	0.000566	CcSEcCtD
Clopidogrel—Rash—Methotrexate—colon cancer	6.5e-05	0.000561	CcSEcCtD
Clopidogrel—Dermatitis—Methotrexate—colon cancer	6.49e-05	0.000561	CcSEcCtD
Clopidogrel—Headache—Methotrexate—colon cancer	6.45e-05	0.000558	CcSEcCtD
Clopidogrel—Nausea—Methotrexate—colon cancer	6.12e-05	0.000529	CcSEcCtD
Clopidogrel—ABCB1—lymph node—colon cancer	6.08e-05	0.00639	CbGeAlD
